Concordance and Discordance of Endometrial Biopsy vs Hysterectomy Specimen Findings for the Diagnosis of Endometrial Cancer

• Anju Khairwa

  Departments of Pathology, University College of Medical Sciences and GTB hospital, Delhi- 110095, India

• Pooja Sharma

  Departments of Pathology, University College of Medical Sciences and GTB hospital, Delhi- 110095, India

• Sonal Sharma

  Departments of Pathology, University College of Medical Sciences and GTB hospital, Delhi- 110095, India

Background: Endometrial cancer (EC) is the most common malignancy of uterus in the Western World. The literature shows a varied association between biopsy versus hysterectomy specimen findings. The objective of the study is to describe the concordance and discordance between endometrial biopsy vs hysterectomy specimens for the detection and grading of EC.

Methods: This is a retrospective cross-sectional analytical study. Data were reviewed from 2018 to 2021 from the departmental archive.

Results: The mean±SD of age was 55.4±9.6 years. The most common clinical feature was postmenopausal bleeding (45.4%). The overall concordance for diagnosis of EC was 59.1% between biopsy and hysterectomy. The highest concordance found for endometrioid carcinoma-NOS was 67.6%. Concordance for overall grading of endometrial cancer was 52.3%, and it was maximum for G1 (78.6%). The strength of association was mild to moderate (C= 0.379 to 0.592) between biopsy vs hysterectomy was significant with the Chi² test. A biopsy had sensitivity, specificity, positive predictive value, and negative predictive value of 67.6%, 57.1%, 89.3%, and 25%, respectively, compared to hysterectomy for diagnosis of EC. Cohen’s Kappa test showed agreement between biopsy and hysterectomy was significant and moderate for the diagnosis EC (59.1%, k=0.1101) and for grading of EC (overall grading-52.2%, k=0.2925, architectural grading- 45.5% k=0.1156, nuclear grading 40.9%, k=0.1746).

Conclusion: Concordance/agreement between endometrial biopsy and hysterectomy was moderate for the diagnosis and grading of EC. The accuracy of biopsy is moderate in diagnosis of EC. We recommend endometrial biopsy as a minimally invasive surgical and cost-effective approach in resource-poor countries.

[1] Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet 2005; 366: 491-505.

[2] Center for Disease Control and Prevention.United States cancer statistics: 1999-2014 incidence and mortality web-based report [database]. 2017. http: //www.cdc.gov/uscs Accessed April 15, 2018.

[3] Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM.Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127(2): 2893-917.

[4] Balasubramaniam G, Sushama S, B Rasika, U Mahantshetty. Hospital-based Study of Endometrial Cancer Survival in Mumbai, India.Asian Pac J Cancer Prev 2013; 14: 977-80.

[5] Kacalska-Janssen O, Rajtar-Ciosek A, Zmaczyński A, et al. Markers of insulin resistance in perimenopausal women with endometrial pathology. Ginekol Pol 2013; 84: 922-929.

[6] Management of endometrial cancer. ACOG Practice Bulletin No. 65.American College of Obstetricians and Gynecologist. Obstet Gynecol 2005; 106: 413-425.

[7] Gredmark T, Kvint S, Havel G, et al. Histopathologicalfindings in women with postmenopausal bleeding. BJOG 1995; 102: 133-136.

[8] Lacey JV Jr, Sherman ME, Rush BB, et al. Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia. J Clin Oncol 2010; 28: 788-792.

[9] Trimble CL, Kauderer J, Zaino R, et al. Concurrentendometrialcarcinoma in women with a biopsydiagnosis of atypicalendometrialhyperplasia: a Gynecologic Oncology Group study. Cancer. 2006; 106: 812-819.

[10] Soslow RA,Tornos C, Park KJ, Malpica A, Guiu XM, Oliva E, et al. Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.Int J Gynecol Pathol 2019; 38: S64-S74.

[11] Amant F, Moerman P, Neven P, et al. Endometrial cancer. Lancet 2005; 366: 491-505.

[12] Sussman I, Prystowsky MB. Pathology service line: a model for accountable care organizations at an academic medical centre. Hum Pathol 2012; 43: 629-631.

[13] Robboy SJ, Weintraub S, Horvath AE, et al. Pathologistworkforce in the United States: I, development of a predictivemodel to examine factors influencing supply. Arch Pathol Lab Med 2013; 137: 1723-1732.

[14] Gross DJ, Kennedy M, Kothari T, et al. The role of the pathologist in population health. Arch Pathol Lab Med.2019; 143: 610-620.

[15] Kisielewski F, Gajewska ME, Marczewska MJ, Panek G, Wielgoś M, Kamiński P. Comparison of endometrial biopsy and postoperative hysterectomy specimen findings in patients with atypical endometrial hyperplasia. Ginekologia Polska 2016; 87: 488-492.

[16] Bryant BH, Doughty E, Kalof AN. Selective vs Complete Sampling in Hysterectomy Specimens Performed for Atypical Hyperplasia. Am J Clin Pathol 2019; XX: 1-9.

[17] Wang X, Huang Z, Di W, Lin Q. Comparison of D & C and hysterectomy pathologic findings in endometrial cancer patients. Arch Gynecol Obstet 2005: 272: 136-141.

[18] Petersen RW, Quinlivan JA, Casperl GR, Nicklid JL. Endometrial adenocarcinoma - presenting pathology is a poor guide to surgical management. Aust NZ J Obstet Gynoecol 2000; 40 (2): 191-194.

[19] Engel JS, Tran J, Khalil N. A systematic review of perioperative clinical practice guidelines for care of older adults living with frailty. Bri J of Anes 2023; 130(3): 262-271.

[20] Yasen Z, Robinson AP, Woffenden H.Advanced Preoperative Planning Techniques in the Management of Complex proximal Humerus Fractures. Cureus 2024; 16(1): e51551.

[21] Vorgias G, Lekka J, Katsoulis M, Varhalama E, Kalinoglou N, Akrivos T. Diagnostic accuracy of prehysterectomy curettage in determining tumour type and grade in patients with endometrial cancer. Med Gen Med 2003; 5(4): 7. PMID: 14745354.

[22] AI Nemer AM, Al Bayat MI, Al Qahtani NH.The accuracy of endometrial sampling for the diagnosis of patterns of endometrial pathology in women presenting with abnormal uterine bleeding. More conservative therapeutic approaches. Saudi Med J 2019; 40 (8): 815-819.

• PDF

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.